Total amount: € 0,00
HOW TO ORDER
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
A Journal on Dermatology and Sexually Transmitted Diseases
Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014
Giornale Italiano di Dermatologia e Venereologia 2000 December;135(6):669-73
Psoriasis and quality of life in Italy. Dermatoproject
Cainelli T. 1, Caputo R. 2, Clerici S. 3, Lisi P. 4, Maffei C. 3, Santojanni P. 5, Viaggi S. 6, Bellei S. 6, Fiori G. 6, Garavaglia A. 7
1 Clinica Dermatologica dell’Università di Milano-Bicocca presso gli Ospedali Riuniti di Bergamo
2 Istituto di Scienze Dermatologiche, Università di Milano I.R.C.C.S. Ospedale Maggiore Milano
3 Dipartimento di Scienze Neuropsichiche, Servizio di Psicologia Clinica e Psicoterapia Università Vita-Salute San Raffaele UHSR - Milano
4 Dipartimento di Specialità medico-chirurgiche, Sezione di dermatologia allergologica e ambientale Università di Perugia
5 Clinica Dermatologica, Università Federico II - Napoli
6 Divisione Studi e Ricerche, Link Italia - Modena.
7 Recordati S.p.A. - Milano
Background. Dermaproject is a multi-center, prospective observational study aimed at assessing the quality of life (QoL) of Italian patients with psoriasis.
Methods. From January to May 1999, Dermaproject has enrolled 1232 patients in 49 Dermatological Centers widely distributed throughout Italy. To be enrolled into the study, the patients had to satisfy the following criteria: 1) new or previous diagnosed psoriasis, 2) age ≥18 years and, 3) ability to compile the QoL questionnaires. Each patient will undergo a follow-up visit at 1 year from enrollment. QoL is measured by means of specific (QUAVIDERM) and more generic health questionnaires (SF-36 and SCL-90).
Results. The study population is made of males aged 48.8±15.9 years (mean ±SD) for 61.4% and by females aged 46.6±17.0 years for 48.6%. Newly diagnosed cases of psoriasis make up 20.4% of this population. The follow-up of patients will be concluded by the end of summer 2000.
Conclusions. Dermaproject is expected to offer a nationally representative picture of QoL of patients with psoriasis in Italy.